Browse by Medical Category
Accepting New Patients
Go To Programs
MassGeneral Hospital for Children
Go To Specialties
Dr. Carroll holds an MPH in International Health and an MD with a focus in International Health. His clinical practice is mainly in the pediatric ICU at MGHfC and he maintains research efforts in the pathophysiology of severe malaria and appropriate medical technology development for low- and middle-income country settings. He divides his time between Boston, Uganda, India, and South America.
View my most recent publications at PubMed
Bergmark B, Bergmark R, De Beaudrap P, Boum Y, Mwanga-Amumpaire J, Carroll R, Zapol W. Inhaled Nitric Oxide and Cerebral Malaria: Basis of a Strategy for Buying Time for Pharmacotherapy. Pediatr Infect Dis J. December 2012; 31(12): e250 ? 254.
Ackerman H, Carroll R. Casals-Pascual C. A better biomarker for cerebral malaria: In the eyes of the beheld? Editorial. Crit Care Med. May 2012; 40(3): 1018 ? 1020.
Ryan W. Carroll, Wainwright MS, Kim K-Y, Kidambi T, G?mez ND, et al. A rapid murine coma and behavior scale for quantitative assessment of murine cerebral malaria. PLoS ONE. 2010; 5(10): e13124.
Drs. Warren Zapol and Ryan Carroll of the Anesthesiology Center for Critical Care Research and are currently leading a phase II clinical trial in the safety and efficacy of inhaled nitric oxide as an adjunctive treatment for pediatric patients with cerebral malaria in Uganda (ClinicalTrial.gov: NCT01388842).
Back to Top